FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Saturday

 

Biogen, Siemens Healthineers to quantify MRI analysis for MS






























MS torchbearer Biogen is joining forces with Siemens Healthineers to develop MRI applications to quantify “key markers” indicating disease activity and progression.

Physicians already use MRI to diagnose MS, a disease in which the immune system attacks the central nervous system and which can cause tremors, memory problems, blindness and paralysis, among other symptoms. But doctors currently assess MRI scans qualitatively, comparing a patient’s latest MRI with the previous one.

Studies have shown that quantitative MRI analysis may provide a more comprehensive look at a patient’s prognosis and response to therapy, according to the companies. But quantitative measures tend to be available only for research, they said in a statement.

The pair will work on quantitative metrics for MRI scans that can improve decision-making in a clinical setting.

"Our shared goal is to create a solution that can be integrated into the existing radiology workflow, so it can become a seamless part of routine care—delivering new and valuable information to treating neurologists, without increasing the cost or burden on the healthcare system," said Christoph Zindel, M.D., senior vice president of magnetic resonance imaging at Siemens Healthineers, in the statement.

"Biogen believes that the availability of high-quality, standardized data at the point of care can lead to a deeper understanding of MS, more informed treatment decisions and, ultimately, improved patient outcomes,” said Richard Rudick, M.D., vice president of development sciences at Biogen. "We also recognize that the ability to generate research-quality data in the course of routine clinical practice can unlock the potential of the health care system to move towards precision medicine."al, it was approved with a boxed warning on safety risks, including liver injury.

Story Source: The above story is based on materials provided by FIERCEBIOTECH
Note: Materials may be edited for content and length


Go to Newer News Go to Older News